Swiss healthtech startup Hedera Dx has secured €15 million in a Series A funding round to scale its precision oncology platform, designed to help hospitals offer advanced cancer diagnostics and treatments.
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?